Deals
IMS CEO’s $25.9 Million Pay Tops Biggest Health Companies
This article is for subscribers only.
IMS Health Holdings Inc. paid its CEO $25.9 million for last year, making Ari Bousbib better compensated than the heads of some of the biggest health-care companies in the U.S., despite IMS being only a fraction of their size and posting a 2014 loss.
Johnson & Johnson, for comparison, is the world’s biggest maker of health-care products with $74.3 billion of sales last year. IMS sold $2.64 billion last year -- 3.6 percent of what J&J did. Pfizer Inc., the biggest U.S. drugmaker, has a market capitalization about 25 times that of IMS.